BICLUSTER_ID : UPREG-232
PATHOGENS /2/ : streptococcus pneumoniae,ehrlichia chaffeensis
TARGETS /7/ : ABCC4, TNFRSF1A, SELP, JUN, CD55, PLAUR, BMP2
Gene SetLeading Edge Genes
NETPATH IL 6 PATHWAY UPSGK, ABCC4, GADD45B, CXCL1, CEBPD, JUN, MCL1, JUNB, HBEGF, MAP3K8, CDKN1B, SLC2A3, SOCS3, MAFF, ZFP36, FOS, PRDM1
NETPATH IL 5 PATHWAY UPIRF2, SELP, BIRC3, NFKBIE, DUSP6, CD55, PRDM1, EGR2, IER3
NETPATH IL 4 PATHWAY UPRGS2, STK17B, SSBP2, KLF4, BCL2L11, DUSP6, BMP2, TOX, SOCS3, ELAVL2, HSPB8, ARHGAP25, FOS, GNAI1, EGR2
GERY CEBP TARGETSRGS2, GADD45B, CXCL1, KLF4, GADD45G, RGS16, FOS, DUSP1, PLAUR, PER2, BTG2
NETPATH KIT RECEPTOR PATHWAY UPTNFRSF1A, MCL1, FOS, IER3
NETPATH IL 2 PATHWAY UPSTK17B, KLF6, GADD45G, DUSP6, SLC2A3, RGS16, PMAIP1, SOCS3, PBEF1, FOS, PLAUR, IER3, PER2
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
NETPATH IL 9 PATHWAY UPSOCS3
LINDGREN BLADDER CANCER CLUSTER 2B
VARELA ZMPSTE24 TARGETS UP
RODRIGUES NTN1 AND DCC TARGETS
SWEET LUNG CANCER KRAS UP
CHEN LVAD SUPPORT OF FAILING HEART UP
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION B
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT DN
VALK AML CLUSTER 1
AMIT EGF RESPONSE 40 HELA
NETPATH IL 7 PATHWAY UPCXCL1, IGLL1, MCL1, CCL19, CXCL2
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
CORUM MCL1-NOXA COMPLEX
MORI EMU MYC LYMPHOMA BY ONSET TIME DN
NAKAYAMA FRA2 TARGETS
JEON SMAD6 TARGETS UP
CHAUHAN RESPONSE TO METHOXYESTRADIOL DN
SARRIO EPITHELIAL MESENCHYMAL TRANSITION DN
MITSIADES RESPONSE TO APLIDIN UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
NCI IL6 7PATHWAYSOCS3, CEBPD, MCL1, MAP2K6, FOS
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
LENAOUR DENDRITIC CELL MATURATION DN
BOYAULT LIVER CANCER SUBCLASS G56 DN
HINATA NFKB TARGETS KERATINOCYTE UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
NCI HIF1 TFPATHWAY
OSADA ASCL1 TARGETS DN
DONATO CELL CYCLE TRETINOIN
DUTTA APOPTOSIS VIA NFKB
DUNNE TARGETS OF AML1 MTG8 FUSION DN
PAL PRMT5 TARGETS DN
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER DN
TSAI RESPONSE TO IONIZING RADIATION
KRISHNAN FURIN TARGETS UP
CORUM RIBOSOME CYTOPLASMIC
DIRMEIER LMP1 RESPONSE EARLY
AMIT SERUM RESPONSE 240 MCF10A
MCMURRAY TP53 HRAS COOPERATION RESPONSE UP
SEMENZA HIF1 TARGETS
MARSON FOXP3 TARGETS UP
ZHOU INFLAMMATORY RESPONSE LIVE UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN
ONDER CDH1 TARGETS 3 DN
AMIT EGF RESPONSE 120 HELA
DEBOSSCHER NFKB TARGETS REPRESSED BY GLUCOCORTICOIDS
DANG REGULATED BY MYC DN
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
LAU APOPTOSIS CDKN2A DN
PARK TRETINOIN RESPONSE
MCLACHLAN DENTAL CARIES UP
HENDRICKS SMARCA4 TARGETS DN
VARELA ZMPSTE24 TARGETS DN
PODAR RESPONSE TO ADAPHOSTIN UP
FOSTER INFLAMMATORY RESPONSE LPS DN
LEE LIVER CANCER E2F1 UP
TAVOR CEBPA TARGETS UP
NCI VIRAL MRNA TRANSLATIONRPS15A, RPL35, RPS11, RPS25, RPL23A, RPS6, RPS10, RPS21, RPS5, RPS28, RPL18, RPL32, RPS9, RPL13, RPS23, RPL11, RPS19, RPL30, FAU, RPS7, RPL39, RPL8, RPLP2, RPS8, RPL28, RPL13A, RPL35A, RPS27, RPS20, RPS3
REACTOME VIRAL MRNA TRANSLATION
GAURNIER PSMD4 TARGETS
NCI EUKARYOTIC TRANSLATION TERMINATION
NCI PEPTIDE CHAIN ELONGATION
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
ZHOU INFLAMMATORY RESPONSE LPS UP
GESERICK TERT TARGETS DN
AMIT SERUM RESPONSE 120 MCF10A
NETPATH IL 3 PATHWAY DOWN
MARSON FOXP3 TARGETS STIMULATED UP
SESTO RESPONSE TO UV C3
NCI IL2 1PATHWAY
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
CHANDRAN METASTASIS TOP50 DN
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
MA PITUITARY FETAL VS ADULT UP
SPIRA SMOKERS LUNG CANCER UP
TIAN TNF SIGNALING VIA NFKB
NETPATH IL 1 PATHWAY UPCHI3L1, NFKBIA, BIRC3, CXCL1, PBEF1, NFKBIE, CXCL2
GOLUB ALL VS AML DN
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION MONOCYTE DN
AMIT EGF RESPONSE 60 MCF10A
HINATA NFKB TARGETS FIBROBLAST UP
RHEIN ALL GLUCOCORTICOID THERAPY UP
CHEN HOXA5 TARGETS 6HR UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
NCI ATF2 PATHWAY
LEONARD HYPOXIA
NCI FORMATION OF A POOL OF FREE 40S SUBUNITS
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 0
MAINA HYPOXIA VHL TARGETS UP
CROONQUIST STROMAL STIMULATION UP
LEE LIVER CANCER MYC TGFA UP
BERENJENO TRANSFORMED BY RHOA REVERSIBLY DN
HALMOS CEBPA TARGETS UP
ONDER CDH1 TARGETS 1 UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
SAGIV CD24 TARGETS DN
KHETCHOUMIAN TRIM24 TARGETS UP
KEGG MAPK SIGNALING PATHWAY
KRIGE RESPONSE TO TOSEDOSTAT 24HR UP
NCI CMYB PATHWAY
NETPATH IL 4 PATHWAY DOWNCHI3L1, NFKBIA, GEM, GADD45B, CXCL2, CDKN1B
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
CASORELLI APL SECONDARY VS DE NOVO UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
GAUTSCHI SRC SIGNALING
EHRLICH ICF SYNDROM DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
HARRIS HYPOXIA
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
CORUM 40S RIBOSOMAL SUBUNIT CYTOPLASMIC
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
BIOCARTA CYTOKINE PATHWAY
SEIKE LUNG CANCER POOR SURVIVAL
AMIT EGF RESPONSE 20 HELA
SCHLESINGER METHYLATED DE NOVO IN CANCER
MUELLER METHYLATED IN GLIOBLASTOMA
KAN RESPONSE TO ARSENIC TRIOXIDE
BASSO CD40 SIGNALING UP
BIOCARTA NTHI PATHWAY
TIAN TNF SIGNALING NOT VIA NFKB
NAGASHIMA NRG1 SIGNALING UP
MARZEC IL2 SIGNALING UP
SOUCEK MYC TARGETS
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
ZERBINI RESPONSE TO SULINDAC UP
BILBAN B CLL LPL DN
WANG ESOPHAGUS CANCER VS NORMAL UP
FRIDMAN SENESCENCE UP
MAHADEVAN RESPONSE TO MP470 UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC UP
FERRARI RESPONSE TO FENRETINIDE UP
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
NETPATH IL 3 PATHWAY UPSOCS3, MCL1, FOS
CHO NR4A1 TARGETS
LEE LIVER CANCER ACOX1 UP
RUTELLA RESPONSE TO HGF DN
WANG ESOPHAGUS CANCER PROGRESSION UP
REACTOME PEPTIDE CHAIN ELONGATION
WU HBX TARGETS 1 UP
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
BERENJENO TRANSFORMED BY RHOA FOREVER DN
CHEN HOXA5 TARGETS 9HR UP
DAZARD UV RESPONSE CLUSTER G2
AMIT SERUM RESPONSE 40 MCF10A
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
PARK TRETINOIN RESPONSE AND PML RARA FUSION
ENGELMANN CANCER PROGENITORS UP
MARSON FOXP3 TARGETS DN
SENESE HDAC1 AND HDAC2 TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D DN
XU HGF TARGETS INDUCED BY AKT1 6HR
ONDER CDH1 TARGETS 2 DN
ODONNELL TARGETS OF MYC AND TFRC UP
INGA TP53 TARGETS
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
SENESE HDAC3 TARGETS UP
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
YAO HOXA10 TARGETS VIA PROGESTERONE UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
REACTOME FORMATION OF A POOL OF FREE 40S SUBUNITS
GOUYER TATI TARGETS UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
ZUCCHI METASTASIS DN
LU IL4 SIGNALING
BIOCARTA ARENRF2 PATHWAY
PRAMOONJAGO SOX4 TARGETS UP
WATTEL AUTONOMOUS THYROID ADENOMA DN
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
streptococcus pneumoniae tigr4ehrlichia chaffeensis libertyGeneSet Name
0.00000 0.00150NETPATH_IL_6_PATHWAY_UP
0.00002 0.05924NETPATH_IL_5_PATHWAY_UP
0.00685 0.02314NETPATH_IL_4_PATHWAY_UP
0.00001 0.05794GERY_CEBP_TARGETS
0.00001 0.05936NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.07061 0.01786NETPATH_IL_2_PATHWAY_UP
0.00058 0.01105GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.05141 0.00207NETPATH_IL_9_PATHWAY_UP
0.08490 0.00007LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.00000 0.00228VARELA_ZMPSTE24_TARGETS_UP
0.00007 0.18084RODRIGUES_NTN1_AND_DCC_TARGETS
0.15960 0.11487SWEET_LUNG_CANCER_KRAS_UP
0.00000 0.02396CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.00292 0.00032TENEDINI_MEGAKARYOCYTE_MARKERS
0.00796 0.02223LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00000 0.09956RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.15403 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.19106 0.01520GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.00046 0.07903VALK_AML_CLUSTER_1
0.00000 0.15480AMIT_EGF_RESPONSE_40_HELA
0.00009 0.00005NETPATH_IL_7_PATHWAY_UP
0.00224 0.03802YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.16680 0.14845CORUM_MCL1-NOXA_COMPLEX
0.04977 0.00853MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.01710 0.01115NAKAYAMA_FRA2_TARGETS
0.11902 0.03458JEON_SMAD6_TARGETS_UP
0.16613 0.05527CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.05292 0.09096SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
0.00323 0.14846MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00077 0.01294THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.00381 0.00014NCI_IL6_7PATHWAY
0.07760 0.06656TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.02611 0.00000LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.00130 0.04554BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.00741 0.00058HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.02561 0.00966KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00001 0.12897NCI_HIF1_TFPATHWAY
0.09859 0.00584OSADA_ASCL1_TARGETS_DN
0.16575 0.11914DONATO_CELL_CYCLE_TRETINOIN
0.00090 0.00023DUTTA_APOPTOSIS_VIA_NFKB
0.10735 0.15511DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN
0.02551 0.00993PAL_PRMT5_TARGETS_DN
0.13655 0.16740SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN
0.03596 0.05204TSAI_RESPONSE_TO_IONIZING_RADIATION
0.08033 0.01482KRISHNAN_FURIN_TARGETS_UP
0.09762 0.01621CORUM_RIBOSOME_CYTOPLASMIC
0.00000 0.00342DIRMEIER_LMP1_RESPONSE_EARLY
0.07436 0.17684AMIT_SERUM_RESPONSE_240_MCF10A
0.16968 0.01999MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.00001 0.10625SEMENZA_HIF1_TARGETS
0.15203 0.00092MARSON_FOXP3_TARGETS_UP
0.00172 0.05362ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.15086 0.01422RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.00000 0.16184ONDER_CDH1_TARGETS_3_DN
0.00000 0.00639AMIT_EGF_RESPONSE_120_HELA
0.18502 0.16474DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.00565 0.18816DANG_REGULATED_BY_MYC_DN
0.05863 0.04791NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.11106 0.19323LAU_APOPTOSIS_CDKN2A_DN
0.10180 0.00554PARK_TRETINOIN_RESPONSE
0.18322 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.00439 0.07669HENDRICKS_SMARCA4_TARGETS_DN
0.10625 0.00000VARELA_ZMPSTE24_TARGETS_DN
0.00000 0.00465PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.01424 0.00078FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.09181 0.00413LEE_LIVER_CANCER_E2F1_UP
0.01378 0.04493TAVOR_CEBPA_TARGETS_UP
0.08297 0.02372NCI_VIRAL_MRNA_TRANSLATION
0.07641 0.02961REACTOME_VIRAL_MRNA_TRANSLATION
0.09452 0.00000GAURNIER_PSMD4_TARGETS
0.09169 0.02343NCI_EUKARYOTIC_TRANSLATION_TERMINATION
0.08238 0.03274NCI_PEPTIDE_CHAIN_ELONGATION
0.00028 0.09089SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.05005 0.03822ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.00000 0.00164GESERICK_TERT_TARGETS_DN
0.00000 0.00533AMIT_SERUM_RESPONSE_120_MCF10A
0.18876 0.03081NETPATH_IL_3_PATHWAY_DOWN
0.17179 0.04704MARSON_FOXP3_TARGETS_STIMULATED_UP
0.00000 0.11456SESTO_RESPONSE_TO_UV_C3
0.13882 0.18437NCI_IL2_1PATHWAY
0.01022 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.00015 0.00011BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.00245 0.09489CHANDRAN_METASTASIS_TOP50_DN
0.03793 0.01274GEISS_RESPONSE_TO_DSRNA_UP
0.00170 0.00118GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.01135 0.17348MA_PITUITARY_FETAL_VS_ADULT_UP
0.00005 0.03806SPIRA_SMOKERS_LUNG_CANCER_UP
0.00001 0.02222TIAN_TNF_SIGNALING_VIA_NFKB
0.00001 0.04640NETPATH_IL_1_PATHWAY_UP
0.16218 0.02336GOLUB_ALL_VS_AML_DN
0.01752 0.02333LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.01422NAGASHIMA_EGF_SIGNALING_UP
0.11071 0.00092TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.00000 0.06686AMIT_EGF_RESPONSE_60_MCF10A
0.00038 0.00960HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00381 0.00739RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.00007 0.13502CHEN_HOXA5_TARGETS_6HR_UP
0.00812 0.00642SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00000 0.09755OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.00028 0.18902NCI_ATF2_PATHWAY
0.00001 0.02395LEONARD_HYPOXIA
0.09078 0.02218NCI_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS
0.19100 0.17885YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.16256 0.04471MAINA_HYPOXIA_VHL_TARGETS_UP
0.00000 0.00903CROONQUIST_STROMAL_STIMULATION_UP
0.14214 0.02710LEE_LIVER_CANCER_MYC_TGFA_UP
0.00179 0.06757BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.00000 0.03077HALMOS_CEBPA_TARGETS_UP
0.06833 0.16841ONDER_CDH1_TARGETS_1_UP
0.12061 0.00209TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.00002 0.07135SAGIV_CD24_TARGETS_DN
0.02288 0.00030KHETCHOUMIAN_TRIM24_TARGETS_UP
0.03665 0.19862KEGG_MAPK_SIGNALING_PATHWAY
0.16308 0.14830KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
0.12428 0.17873NCI_CMYB_PATHWAY
0.01938 0.00340NETPATH_IL_4_PATHWAY_DOWN
0.00068 0.03335GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.00845 0.02398CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP
0.07880 0.00000RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.03607 0.12005GAUTSCHI_SRC_SIGNALING
0.03720 0.09374EHRLICH_ICF_SYNDROM_DN
0.07890 0.00580CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.00000 0.03906HARRIS_HYPOXIA
0.09743 0.00000FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.11138 0.01564CORUM_40S_RIBOSOMAL_SUBUNIT_CYTOPLASMIC
0.00000 0.02975CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.00002 0.00766DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.10346 0.02223BIOCARTA_CYTOKINE_PATHWAY
0.05865 0.01750SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.00019 0.00673AMIT_EGF_RESPONSE_20_HELA
0.07761 0.17630SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
0.11195 0.02943MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.00024 0.19460KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.01887 0.00000BASSO_CD40_SIGNALING_UP
0.14147 0.01296BIOCARTA_NTHI_PATHWAY
0.00000 0.02313TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00000 0.00351NAGASHIMA_NRG1_SIGNALING_UP
0.01084 0.04723MARZEC_IL2_SIGNALING_UP
0.02991 0.00038SOUCEK_MYC_TARGETS
0.04093 0.08988TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.00038 0.13115ZERBINI_RESPONSE_TO_SULINDAC_UP
0.00001 0.00006BILBAN_B_CLL_LPL_DN
0.16764 0.15201WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.06538 0.08258FRIDMAN_SENESCENCE_UP
0.05724 0.00131MAHADEVAN_RESPONSE_TO_MP470_UP
0.00350 0.09163TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.00024 0.18558FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.00000 0.05938BILD_HRAS_ONCOGENIC_SIGNATURE
0.13850 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.00000 0.06350DAUER_STAT3_TARGETS_UP
0.00810 0.00030NETPATH_IL_3_PATHWAY_UP
0.11862 0.18281CHO_NR4A1_TARGETS
0.10301 0.05856LEE_LIVER_CANCER_ACOX1_UP
0.01162 0.00008RUTELLA_RESPONSE_TO_HGF_DN
0.03617 0.07674WANG_ESOPHAGUS_CANCER_PROGRESSION_UP
0.08109 0.03578REACTOME_PEPTIDE_CHAIN_ELONGATION
0.00585 0.01391WU_HBX_TARGETS_1_UP
0.00000 0.02827ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00046 0.12473BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.00003 0.02231CHEN_HOXA5_TARGETS_9HR_UP
0.00000 0.05324DAZARD_UV_RESPONSE_CLUSTER_G2
0.00000 0.03677AMIT_SERUM_RESPONSE_40_MCF10A
0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00000 0.00022GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00001 0.00059ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.14027 0.00521PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.05987 0.04783ENGELMANN_CANCER_PROGENITORS_UP
0.05157 0.11915MARSON_FOXP3_TARGETS_DN
0.05989 0.03587SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.15405 0.00033TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.05262 0.02953XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.10479 0.03586ONDER_CDH1_TARGETS_2_DN
0.02726 0.02393ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.00001 0.01560INGA_TP53_TARGETS
0.00000 0.02652HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.11682 0.17909SENESE_HDAC3_TARGETS_UP
0.00000 0.10221UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.09671 0.09161XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.02492 0.03620YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP
0.00000 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00000 0.00033GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.08242 0.02849REACTOME_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS
0.15861 0.06698GOUYER_TATI_TARGETS_UP
0.00000 0.10357OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00000 0.05374ZUCCHI_METASTASIS_DN
0.17647 0.00508LU_IL4_SIGNALING
0.00046 0.12804BIOCARTA_ARENRF2_PATHWAY
0.00000 0.12936PRAMOONJAGO_SOX4_TARGETS_UP
0.00001 0.07019WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.00000 0.01248PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.00069 0.01294YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1